Literature DB >> 18200429

Prognostic models for predicting death after hepatectomy in individuals with hepatic metastases from colorectal cancer.

Yukihide Kanemitsu1, Tomoyuki Kato.   

Abstract

BACKGROUND: Appropriate cancer treatment policies should include an accurate estimate of a patient's baseline risk of death, determined by the tumor load. Few prognostic models have reached the stage at which they can be used to select patients who would benefit from hepatectomy for metastatic colorectal cancer. Establishing the prognosis of patients with hepatic metastases from colorectal cancer is an important part of their evaluation and treatment.
METHODS: Pre- and post-treatment prognostic nomograms were developed using Cox regression and multiple imputation from 578 patients with hepatic metastases from colorectal cancer who were candidates for hepatectomy.
RESULTS: The preoperative nomogram included the following prognostic factors: primary histology, number of metastatic lymph nodes associated with the primary lesion, number of hepatic tumors, extrahepatic disease, and prehepatectomy carcinoembryonic antigen level. Plots of predicted versus actual outcomes suggested that the nomogram was well calibrated for predicting death after hepatectomy. The concordance index of the nomogram was 0.66, higher than those of other models for hepatic metastatic colorectal cancer in the literature. A postoperative nomogram was also prepared.
CONCLUSIONS: These models have improved predictive ability in individuals with hepatic metastases from colorectal cancer, which may be helpful in counseling patients and making treatment decisions.

Entities:  

Mesh:

Year:  2008        PMID: 18200429     DOI: 10.1007/s00268-007-9348-0

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  30 in total

Review 1.  Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors.

Authors:  F E Harrell; K L Lee; D B Mark
Journal:  Stat Med       Date:  1996-02-28       Impact factor: 2.373

2.  Evaluating the yield of medical tests.

Authors:  F E Harrell; R M Califf; D B Pryor; K L Lee; R A Rosati
Journal:  JAMA       Date:  1982-05-14       Impact factor: 56.272

3.  Treatment of primary colon cancer with peritoneal carcinomatosis: comparison of concomitant vs. delayed management.

Authors:  S R Pestieau; P H Sugarbaker
Journal:  Dis Colon Rectum       Date:  2000-10       Impact factor: 4.585

4.  Bootstrap investigation of the stability of a Cox regression model.

Authors:  D G Altman; P K Andersen
Journal:  Stat Med       Date:  1989-07       Impact factor: 2.373

5.  Liver resection for colorectal metastases.

Authors:  Y Fong; A M Cohen; J G Fortner; W E Enker; A D Turnbull; D G Coit; A M Marrero; M Prasad; L H Blumgart; M F Brennan
Journal:  J Clin Oncol       Date:  1997-03       Impact factor: 44.544

6.  OncoSurge: a strategy for improving resectability with curative intent in metastatic colorectal cancer.

Authors:  Graeme J Poston; René Adam; Steven Alberts; Steven Curley; Juan Figueras; Daniel Haller; Francis Kunstlinger; Gilles Mentha; Bernard Nordlinger; Yehuda Patt; John Primrose; Mark Roh; Philippe Rougier; Theo Ruers; Hans Joachim Schmoll; Carlos Valls; Nick Jean-Nicolas Vauthey; Marleen Cornelis; James P Kahan
Journal:  J Clin Oncol       Date:  2005-10-01       Impact factor: 44.544

7.  Tumor progression while on chemotherapy: a contraindication to liver resection for multiple colorectal metastases?

Authors:  René Adam; Gerard Pascal; Denis Castaing; Daniel Azoulay; Valerie Delvart; Bernard Paule; Francis Levi; Henri Bismuth
Journal:  Ann Surg       Date:  2004-12       Impact factor: 12.969

8.  Extrahepatic disease does not contraindicate hepatectomy for colorectal liver metastases.

Authors:  D Elias; J-F Ouellet; N Bellon; J-P Pignon; M Pocard; P Lasser
Journal:  Br J Surg       Date:  2003-05       Impact factor: 6.939

9.  Attitude and self-reported practice regarding prognostication in a national sample of internists.

Authors:  N A Christakis; T J Iwashyna
Journal:  Arch Intern Med       Date:  1998-11-23

10.  Experience in hepatic resection for metastatic colorectal cancer: analysis of clinical and pathologic risk factors.

Authors:  T J Gayowski; S Iwatsuki; J R Madariaga; R Selby; S Todo; W Irish; T E Starzl
Journal:  Surgery       Date:  1994-10       Impact factor: 3.982

View more
  22 in total

1.  Identification of patients likely to benefit from metastasectomy in stage IV colorectal cancer.

Authors:  Manabu Shimomura; Masazumi Okajima; Takao Hinoi; Hiroyuki Egi; Yuji Takakura; Yasuo Kawaguchi; Masakazu Tokunaga; Tomohiro Adachi; Hirotaka Tashiro; Hideki Ohdan
Journal:  Int J Colorectal Dis       Date:  2012-03-10       Impact factor: 2.571

2.  Prognostic models for predicting death after hepatectomy in individuals with hepatic metastases from colorectal cancer.

Authors:  M D Smith; R W Parks
Journal:  World J Surg       Date:  2008-06       Impact factor: 3.352

3.  Predicting Overall Survival in Patients with Metastatic Rectal Cancer: a Machine Learning Approach.

Authors:  Beiqun Zhao; Rodney A Gabriel; Florin Vaida; Nicole E Lopez; Samuel Eisenstein; Bryan M Clary
Journal:  J Gastrointest Surg       Date:  2019-08-29       Impact factor: 3.452

Review 4.  Rationale for ablation of oligometastatic disease and the role of stereotactic body radiation therapy for hepatic metastases.

Authors:  Chad G Rusthoven; Tracey E Schefter
Journal:  Hepat Oncol       Date:  2013-12-20

Review 5.  Role of stereotactic body radiotherapy for oligometastasis from colorectal cancer.

Authors:  Atsuya Takeda; Naoko Sanuki; Etsuo Kunieda
Journal:  World J Gastroenterol       Date:  2014-04-21       Impact factor: 5.742

6.  Extracapsular lymph node involvement is associated with colorectal liver metastases and impact outcome after hepatectomy for colorectal metastases.

Authors:  Hideki Suzuki; Takaaki Fujii; Takayuki Asao; Soichi Tsutsumi; Satoshi Wada; Kenichiro Araki; Norio Kubo; Akira Watanabe; Mariko Tsukagoshi; Hiroyuki Kuwano
Journal:  World J Surg       Date:  2014-08       Impact factor: 3.352

7.  Modern chemotherapy mitigates adverse prognostic effect of regional nodal metastases in stage IV colorectal cancer.

Authors:  Alan A Thomay; David M Nagorney; Steven J Cohen; Elin R Sigurdson; Mark J Truty; Barbara Burtness; Michael J Hall; Yun Shin Chun
Journal:  J Gastrointest Surg       Date:  2013-09-04       Impact factor: 3.452

8.  Evaluation of peri-operative chemotherapy using a prognostic nomogram for survival after resection of colorectal liver metastases.

Authors:  Srinevas K Reddy; Michael W Kattan; Changhong Yu; Eugene P Ceppa; Sebastian G de la Fuente; Yuman Fong; Bryan M Clary; Rebekah R White
Journal:  HPB (Oxford)       Date:  2009-11       Impact factor: 3.647

9.  Computed Tomography Image Texture: A Noninvasive Prognostic Marker of Hepatic Recurrence After Hepatectomy for Metastatic Colorectal Cancer.

Authors:  Amber L Simpson; Alexandre Doussot; John M Creasy; Lauryn B Adams; Peter J Allen; Ronald P DeMatteo; Mithat Gönen; Nancy E Kemeny; T Peter Kingham; Jinru Shia; William R Jarnagin; Richard K G Do; Michael I D'Angelica
Journal:  Ann Surg Oncol       Date:  2017-05-30       Impact factor: 5.344

Review 10.  Treatment for colorectal liver metastases: a review.

Authors:  Hiroshi Shimada; Kuniya Tanaka; Itaru Endou; Yasushi Ichikawa
Journal:  Langenbecks Arch Surg       Date:  2009-07-07       Impact factor: 3.445

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.